Established and new treatments for hereditary angioedema: An update

Molecular Immunology

Volumn 44, Issue 16, 2007, Pages 3858-3861

  Cicardi, Marco ^a   Zingale, Lorenza ^a   Zanichelli, Andrea ^a   Deliliers, Daniela Lambertenghi ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

C1 inhibitor; HAE; Hereditary angioedema; Therapy

Indexed keywords

BRADYKININ B2 RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; DX 88; ENZYME INHIBITOR; ICATIBANT; KALLIKREIN INHIBITOR; PLACEBO; PLASMA KALLIKREIN; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; BIOLOGICAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG BINDING; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG INHIBITION; DRUG SAFETY; DRUG TOLERABILITY; FLUSHING; GENETIC DISORDER; HUMAN; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINITIS; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANGIONEUROTIC EDEMA; ANIMALS; CONTROLLED CLINICAL TRIALS; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 34548274877     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.06.004     Document Type: Review

References (23)

1. Agostoni A., Aygoren-Pursun E., Binkley K.E., Blanch A., Bork K., Bouillet L., Bucher C., Castaldo A.J., Cicardi M., Davis A.E., De Carolis C., Drouet C., Duponchel C., Farkas H., Fay K., Fekete B., Fischer B., Fontana L., Fust G., Giacomelli R., Groner A., Hack E.C., Harmat G., Jakenfelds J., Juers M., Kalmar L., Kaposi P.N., Karadi I., Kitzinger A., Kollar T., Kreuz W., Lakatos P., Longhurst H.J., Lopez-Trascasa M., Martinez-Saguer I., Monnier N., Nagy I., Nemeth E., Nielsen E.W., Nuijens J.H., O'Grady C., Pappalardo E., Penna V., Perricone C., Perricone R., Rauch U., Roche O., Rusicke E., Spath P.J., Szendei G., Takacs E., Tordai A., Truedsson L., Varga L., Visy B., Williams K., Zanichelli A., and Zingale L. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J. Allergy Clin. Immunol. 114 (2004) S51-S131
2. Agostoni A., Bergamaschini L., Martignoni G., Cicardi M., and Marasini B. Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate. Ann. Allergy 44 (1980) 299-301
3. Anonymous, 2004. Icatibant: HOE 140, JE 049, JE049. Drugs R D 5, 343-348.
4. Bork K., and Barnstedt S.E. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch. Intern. Med. 161 (2001) 714-718
5. Bork K., Frank J., Grundt B., Schlattmann P., Nussberger J., and Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J. Allergy Clin. Immunol. 119 6 (2007) 1497-1503
6. Caballero T., and Lopez-Serrano C. Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema. J. Allergy Clin. Immunol. 117 (2006) 476-477
7. Cicardi M., Bergamaschini L., Marasini B., Boccassini G., Tucci A., and Agostoni A. Hereditary angioedema: an appraisal of 104 cases. Am. J. Med. Sci. 284 (1982) 2-9
8. Davis III A.E. The pathophysiology of hereditary angioedema. Clin. Immunol. 114 (2005) 3-9
9. De Serres J., Groner A., and Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert((R)) P) in hereditary angioedema: a review. Transfus. Apheresis Sci. 29 (2003) 247-254
10. Gadek J.E., Hosea S.W., Gelfand J.A., Santaella M., Wickerhauser M., Triantaphyllopoulos D.C., and Frank M.M. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N. Engl. J. Med. 302 (1980) 542-546
11. Gonzales-Quevedo T., Caballero T., Cicardi M., Bork K., and Williams A. The synthetic Kunitz domain protein Dx88 to treat angioedema in patients with hereditary angioedema. Int. Immunopharmacol. 2 (2002) 1318 (abstract)
12. Kunschak M., Engl W., Maritsch F., Rosen F.S., Eder G., Zerlauth G., and Schwarz H.P. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 38 (1998) 540-549
13. Levi M., Choi G., Picavet C., and Hack C. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J. Allergy Clin. Immunol. 117 (2006) 904-908
14. Longhurst H.J., Carr S., and Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option. Clin. Exp. Immunol. 147 (2007) 11-17
15. Lumry W., Ritchie B., Beck T., and Morrison J. Interim results of EDEMA2, a multicenter, open-label, repeat-dosing study of intravenous and subcutaneous administration of ecallantide (DX-88) in hereditary angioedema. J. Allergy Clin. Immunol. 117 (2006) S179
16. Marasini B., Cicardi M., Martignoni G.C., and Agostoni A. Treatment of hereditary angioedema. Klin. Wochenschr. 56 (1978) 819-823
17. Nuijens J., Verdonk R., Van Doorn M., Burggraaf K., Cohen A., Choi G., Soeters M., Hack C.E., Levi M., Sisk E., and Pinciaro P. Clinical studies of recombinant human C1 inhibitor in subjects with hereditary angioedema. J. Allergy Clin. Immunol. 115 (2005) S 202
18. Prematta M., Gibbs J., Pratt E., Stoughton T., and Craig T. Fresh frozen plasma for the treatment of hereditary angioedema. Ann. Allergy Asthma Immunol. 98 (2007) 383-388
19. van Doorn M.B., Burggraaf J., van Dam T., Eerenberg A., Levi M., Hack C.E., Schoemaker R.C., Cohen A.F., and Nuijens J. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J. Allergy Clin. Immunol. 116 (2005) 876-883
20. Waytes A.T., Rosen F.S., and Frank M.M. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N. Engl. J. Med. 334 (1996) 1630-1634
21. Williams A., and Baird L.G. DX-88 and HAE: a developmental perspective. Transfus. Apheresis Sci. 29 (2003) 255-258
22. Williams T. DX-88, a novel recombinant protein inhibitor of plasma kallikrein: Safety and immunogenicity in early studies. J. Allergy Clin. Immunol. 115 (2005) S181
23. Zingale L.C., Pappalardo E., Zanichelli A., Agostoni A., and Cicardi M. C1 inhibitor concentrate: efficacy and adverse reactions. Int. Immunopharmacol. 318 (2002) 1385 (abstract)